PF3D7_0626300 details

You can find more information about PF3D7_0626300-b-ketoacyl-ACP synthase I using the following links:

PlasmoDB - the Plasmodium genome resource
The TDR Targets Database

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
4-(4-(trifluoromethyl)phenoxy)-5,5-dimethyl-3-propylthiophen-2(5H)-one	QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA(2015)
4-(4-aminosulfonylphenoxy)-3,5,5-trimethylthiophen-2(5H)-one	QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA(2015)
4-(4-chlorophenoxy)-5-ethyl-3,5-dimethylthiophen-2(5H)-one	QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA(2015)
4-(4-fluorophenoxy)-5-ethyl-3,5-dimethylthiophen-2(5H)-one	QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA(2015)
Cerulenin	Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates(2006) Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum(2007)
Sulfonyl-naphthalene-1,4-diols	Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors(2008)
Thiolactomycin	A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum(2003) Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates(2006) Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis(2010) CoMFA, CoMSIA, and docking studies on thiolactone-class of potent anti-malarials: identification of essential structural features modulating anti-malarial activity(2011)
Triclosan	A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum(2003) Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis(2010)